Lipotox Liquid
NDC Package 43857-0636-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Lipotox (squalene, cholesterinum, estradiol, progesterone, aspartame, benzalkonium chloride, formalinum, methylene chloride, methylparaben, propylparaben, sodium benzoate, sodium citrate, titanium dioxide, zincum oxydatum, arsenicum album, lycopodium clavatum, nux vomica, phosphoricum acidum, phosphorus, aceticum acidum, benzoicum acidum, benzyl alcohol, boricum acidum, chlorinum, cortisone aceticum, eugenol, folliculinum, isopropyl palmitate, lacticum acidum, petroleum jelly, phenyl butazone, plumbum metallicum,) liquids is 10 drops orally, 3 times a day. This formulation utilizes a liquid delivery system. Marketed by Bioactive Nutritional, Inc., this product is identified by NDC 43857-0636.

Identification & Billing

NDC Package Code
43857-0636-1
Package Description
30 mL in 1 BOTTLE, DISPENSING
Product Code
11-Digit Billing Format
43857063601

Clinical Specifications

Proprietary Name
Lipotox
Non-Proprietary Name
Squalene, Cholesterinum, Estradiol, Progesterone, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methylparaben, Propylparaben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum, Arsenicum Album, Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Aceticum Acidum, Benzoicum Acidum, Benzyl Alcohol, Boricum Acidum, Chlorinum, Cortisone Aceticum, Eugenol, Folliculinum, Isopropyl Palmitate, Lacticum Acidum, Petroleum Jelly, Phenyl Butazone, Plumbum Metallicum,
Substance Name
Acetic Acid; Anhydrous Trisodium Citrate; Arsenic Trioxide; Aspartame; Benzalkonium Chloride; Benzoic Acid; Benzyl Alcohol; Boric Acid; Chlorine; Cholesterol; Corticotropin; Cortisone Acetate; Estradiol; Estrone; Eugenol; Formaldehyde Solution; Isopropyl Palmitate; Lactic Acid, Dl-; Lead; Lycopodium Clavatum Spore; Methylene Chloride; Methylparaben; Petrolatum; Phenylbutazone; Phosphoric Acid; Phosphorus; Potassium Sorbate; Progesterone; Propylparaben; Resorcinol; Salicylic Acid; Sodium Benzoate; Sorbitol; Squalene; Stearyl Alcohol; Strychnos Nux-vomica Seed; Titanium Dioxide; Xylitol; Zinc Oxide
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.

Regulatory & Marketing

Labeler Name
Bioactive Nutritional, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
09-05-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43857-0636-1 identifies a specific commercial package of 30 ml in 1 bottle, dispensing of Lipotox, a human over the counter drug labeled by Bioactive Nutritional, Inc.. This liquid is formulated for oral use and contains acetic acid; anhydrous trisodium citrate; arsenic trioxide; aspartame; benzalkonium chloride; benzoic acid; benzyl alcohol; boric acid; chlorine; cholesterol; corticotropin; cortisone acetate; estradiol; estrone; eugenol; formaldehyde solution; isopropyl palmitate; lactic acid, dl-; lead; lycopodium clavatum spore; methylene chloride; methylparaben; petrolatum; phenylbutazone; phosphoric acid; phosphorus; potassium sorbate; progesterone; propylparaben; resorcinol; salicylic acid; sodium benzoate; sorbitol; squalene; stearyl alcohol; strychnos nux-vomica seed; titanium dioxide; xylitol; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioactive Nutritional, Inc. on September 05, 2023. The current certification is valid through December 31, 2026.

How is this Bioactive Nutritional, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43857063601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
43857-0636-1
11-Digit CMS (5-4-2)
43857-0636-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.